60
Participants
Start Date
March 12, 2021
Primary Completion Date
January 5, 2022
Study Completion Date
January 5, 2022
YPEG-rhEPO
YPEG-rhEPO，low dose，were subcutaneous injected once every two weeks for 13 weeks.
YPEG-rhEPO
YPEG-rhEPO，low dose，were subcutaneous injected once every four weeks for 13 weeks.
YPEG-rhEPO
YPEG-rhEPO, high dose，were subcutaneous injected once every two weeks for 13 weeks.
YPEG-rhEPO
YPEG-rhEPO，high dose，were subcutaneous injected once every four weeks for 13 weeks.
The First Affiliated Hospital Of Chengdu Medical college, Chengdu
Beijing Anzhen Hospital,Capital Medical University, Beijing
The Second Affiliated Hospital Of Chongqing Medical University, Chongqing
The First Affiliated Hospital Of Guangzhou Medical University, Guangzhou
The First Affiliated Hospital of Jinan University, Guangzhou
The Third Affiliated Hospital of Sun Yat sen University, Guanzhou
Renmin Hospital of Wuhan University/Hubei General Hospital, Wuhan
The Third Xiangya Hospital Of Central South University, Changsha
Xiangya Hospital Central South University, Changsha
The First Affiliated Hospital Of Baotou Medical college,Inner Mongolia University Of Science and Technology, Hohhot
Huai'an Second People's Hospital/The Affiliated Huaian Hospital Of Xuzhou Medical University, Huai'an
Affiliated Zhongshan Hospital of Dalian University, Dalian
Xi'an Gaoxin Hospital, Xi’an
Tianjin First Central Hospital, Tianjin
Tianjin People's Hospital, Tianjin
The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou
Lishui Municipal Central Hospital, Lishui
First Affiliated Hospital of Zhejiang University
OTHER
Xiamen Amoytop Biotech Co., Ltd.
INDUSTRY